Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The microbial biofilm matrix, primarily composed of extracellular polymeric substances (EPS), is a dynamic and complex scaffold that encases microbial communities. This matrix consists of polysaccharides, proteins, lipids, and extracellular DNA (eDNA), which together provide structural integrity and protection against environmental stressors, including host immune defenses and antimicrobial agents [1]. Associated cell surface properties, such as adhesins, pili, and fimbriae, are crucial for the initial attachment of cells to surfaces and for maintaining the cohesive strength of the biofilm [2]. In clinical contexts, the matrix acts as a physical and chemical barrier that contributes significantly to the high level of antibiotic tolerance observed in chronic infections, such as those found in cystic fibrosis or on indwelling medical devices [3]. Therapeutic targeting of the matrix involves the use of enzymes like DNases or glycoside hydrolases to degrade its components, or chelating agents to disrupt the ionic cross-linking that stabilizes the structure [4]. By breaking down this protective shield, these treatments aim to restore the susceptibility of the embedded pathogens to conventional antibiotics and host clearance mechanisms [5]. Sources: [1] Flemming, H. C., & Wingender, J. (2010). Nature Reviews Microbiology; [2] Berne, C., et al. (2018). Nature Reviews Microbiology; [3] Ciofu, O., et al. (2022). Nature Reviews Microbiology; [4] Tetz, G. V., et al. (2009). Antimicrobial Agents and Chemotherapy; [5] Lu, T. K., & Collins, J. J. (2007). PNAS.
Enzymatic degradation of extracellular DNA and polysaccharides, chelation of divalent cations to destabilize the matrix, and reduction of disulfide bonds in matrix proteins.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial biofilm extracellular polymeric substance matrix (EPS matrix) (EPS matrix).